Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Free Cash Flow Generation Index

Latest as of December 2024: -0.06x

Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Free Cash Flow Generation Index of -0.06x as of December 2024. Free cash flow of CN¥-7.20 Million represents 0% of operating cash flow (CN¥122.51 Million). Explore Nanjing Medlander Medical Technology Co. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-0.06x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-7.20 Million
CNY

Operating Cash Flow

CN¥122.51 Million
CNY

Capital Expenditures

CN¥129.71 Million
CNY

Nanjing Medlander Medical Technology Co. Ltd. A Free Cash Flow Generation Index (2020–2024)

Historical FCF Generation Index trend for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. For the full cash flow conversion analysis, see 688273 operating cash flow.

Annual Free Cash Flow Generation for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)

Year-by-year Free Cash Flow Generation Index for Nanjing Medlander Medical Technology Co. Ltd. A. Check 688273 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -0.06x CN¥-7.20 Million CN¥122.51 Million CN¥129.71 Million ▼ -113.0%
2023 0.45x CN¥61.76 Million CN¥136.91 Million CN¥75.15 Million ▼ -21.1%
2022 0.57x CN¥72.41 Million CN¥126.67 Million CN¥54.26 Million ▼ -36.6%
2021 0.90x CN¥134.01 Million CN¥148.60 Million CN¥14.58 Million ▲ +12.4%
2020 0.80x CN¥105.18 Million CN¥131.10 Million CN¥25.91 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).